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Abstract
Collagen-induced arthritis in mice is one of the most commonly
used autoimmune experimental models, with many similarities to
rheumatoid arthritis. Since collagen-induced arthritis is a
complex polygenic disease there is a need for identification of
several major disease-controlling genes. Because rheumatoid
arthritis particularly affects aged women, we have in the present
study identified new genetic regions critical for collagen-
induced arthritis by studying aged female mice of a cross
between NFR/N and B10.Q (H-2q haplotype). The mice in the
present study had different reproductive histories, which did not
significantly affect the onset, incidence or severity of the
disease. A total of 200 female mice were used in a total genome-
wide screening with 125 microsatellite markers. We found one
new significant quantitative trait locus affecting the arthritis
incidence, severity and day of onset on chromosome 11
(denoted Cia40), which colocalizes with a locus controlling
pregnancy failure. Furthermore, a quantitative trait locus of
suggestive significance associated with the incidence, severity
and day of onset was identified on chromosome 1. Finally, a
suggestively significant quantitative trait locus associated with
collagen type II antibody titers was identified on chromosome
13. This study indicates that several gene loci control arthritis in
aged multiparous females, and that at least one of these loci
coincides with pregnancy failure.
Introduction
The similarities between rheumatoid arthritis (RA) in man and
collagen-induced arthritis (CIA) in mice are well established,
although differences in the disease pattern exist [1-3]. Charac-
teristic of RA is the fact that women of reproductive age are
more susceptible to the disease than men [4]. It has also been
reported that 75% of female patients (23 out of 31 females)
with RA exhibit clinical remission during the course of preg-
nancy [5]. On the other hand, it has been suggested that the
onset of RA is postponed by parity. The risk of onset is
reduced during pregnancy, while in the first year postpartum
the chance of onset is increased [6,7]. The results of a recent
study of RA in women, however, indicate that pregnancy his-
tory does not increase the incidence of the disease later in life
[8].
Adequate animal models are useful tools for the identification
of genes involved in complex human diseases. CIA in mice
shares both immunological and pathological characteristics
with human RA and is one of the most used models for the
identification of genes and mechanisms involved in arthritis.
The incidence of CIA is sex dependent, like the incidence in
RA, although different species and different variants of the dis-
ease could lead to both male and female predominance. Male
mice are more often affected than females. Gender differ-
ences in CIA susceptibility are dependent on many factors,
including genetic, hormonal and behavioral influences [9].
However, isolated factors are remarkably consistent between
RA and the different animal models [3,9]. Pregnancy in mice,
like pregnancy in women, normally causes remission of arthri-
tis [5,10], while exacerbation often occurs postpartum
[7,10,11]. Pregnancy-induced remission of CIA in micePage 1 of 6
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the postpartum exacerbation can be explained by the dramatic
drop in estrogen [10], possibly together with increased prol-
actin levels [11]. To what extent the pregnancy history (parity)
affects the incidence of CIA later in life has, to our knowledge,
not previously been studied. Importantly, RA occurs predomi-
nantly in women, many of which have had several children, and
it is therefore appropriate to also mimic this situation using ani-
mal models.
In the present paper we have analyzed female mice that previ-
ously had undergone a reproductive study (Liljander M, Säll-
ström MA, Andersson S, Wernhoff P, Andersson Å, Holmdahl
R, Mattsson R, unpublished data). A total of 200 female mice
(ten months of age) of the N2 backcross between NFR/N and
C57BL/B10.Q (B10.Q) were used to analyze the genetic con-
trol of CIA in aged females with a multiparous history.
Materials and methods
Mice
Inbred NFR/N mice were originally obtained from the National
Institute of Health (Bethesda, MD, USA) and the B10.Q mice
were originally bought from The Jackson Laboratory (Bar Har-
bor, ME, USA). (B10Q × NFR/N)F1 hybrids and (B10.Q ×
NFR/N) × B10.Q N2 mice were bred in individual ventilated
cages in the BMC Barrier animal facility and at the animal
house of the Department of Pathology, Lund University, Swe-
den. The animals were fed ad libitum with standard rodent
chow (LAB FOR R36, irradiated breeding food for rats and
mice; Lactamin AB, Stockholm, Sweden) and water in a pho-
toperiod of 12 hours:12 hours light:dark. The mice used in the
present study had clean health monitoring protocols accord-
ing to the Federation of European Laboratory Animal Sciences
Association recommendations. Ethical permissions were
M125-04 (embryo transfer) and M290-03 (reproduction and
arthritis).
Experimental design
A total of 200 female mice (approximately ten months old) of
N2 backcross (B10.Q × NFR/N) × B10.Q were used. The
mice had earlier undergone a reproductive study where each
animal had four mating opportunities. First, the female mice
were allowed to mate twice with B10.RIII males (allogeneic
mating by means of MHC (major histocompatibility complex)
and finally to mate twice with B10.Q males (syngeneic mating
by means of MHC). After four possible pregnancies CIA was
induced to the female mice.
Induction and evaluation of CIA
To induce CIA, the mice were immunized subcutaneously at
the base of the tail with 100 µg rat collagen type II (CII) emul-
sified in 0.1 M acetic acid combined with an equal amount of
complete Freud's adjuvant (Difco Laboratories, Detroit, MI,
USA). A booster injection containing 50 µg CII emulsified in
0.1 M acetic acid combined with an equal amount of Freud's
incomplete adjuvant (Difco Laboratories) was given after 30
days. The clinical scoring of arthritis commenced 25 days after
the first immunization. Animals were examined for clinical signs
of CIA three times per week and were graded on a 12-point
scale. The arthritis index was assigned to each mouse using
the following criteria: 0 = no visible sign of arthritis, 1 = red-
ness and swelling in a single joint, 2 = inflammation in multiple
joints, and 3 = severe inflammation in the entire paw and/or
anklebone. Each paw was given the scores 0–3, with the index
being the sum of all four paws. The severity trait is the maxi-
mum score observed in each individual female. The onset is
the number of days calculated from the first immunization to
the first clinical signs of arthritis excluding unaffected animals.
Microsatellite genotyping and linkage analysis
Tail biopsies were collected from all N2 females and the F0
generation. DNA was isolated according to a previously
described protocol [12]. After screening of parental DNA with
approximately 450 mouse fluorescence-labeled microsatellite
markers (INTERACTIVA, Ulm, Germany), 125 informative
markers were selected covering the genome. Two hundred
and thirty-seven N2 mice were genotyped with markers cover-
ing all chromosomes except for the Y chromosome. PCR
amplification for the markers was performed in a final volume
of 10 µl in a 96-well V-bottom microtiter plate using 20 ng
DNA, 10 mM KCl, 20 mM Tris–HCl, 10 mM (NH4)2SO4, 2 mM
MgCl2, 0.1% Triton X-100, pH 8.8 (New England BioLabs
Inc., Ipswich, MA, USA), 3 µM (10 pmol) each primer, 2 mM
dNTPs (Advanced Biotechnologies, Epsom, Surrey, UK) and
0.25 U Taq DNA Polymerase (New England BioLabs Inc.). The
following program was used to amplify the DNA: denaturation
at 95°C for 3 minutes, annealing at 56°C for 45 seconds,
polymerization at 72°C for 1 minute, 30 cycles of 95°C for 30
seconds, 56°C for 45 seconds and 72°C for 1 minute, and a
final extension step of 7 minutes at 72°C. The PCR products
were analyzed on a MegaBACE™ 1000 (Amersham Pharma-
cia Biotech Inc Piscataway, NJ, USA) according to the manu-
facturer's protocol. Data were analyzed with Genetic Profiler
1.1 (Amersham Pharmacia Biotech Inc).
Map Manager QTXb20 free software [13] was used to per-
form linkage analysis and the permutation test. Ninety percent
of the mouse genome was within a 20 cM intermarker dis-
tance. The marker map was generated using the Kosambis
map function and 1,000 permutations were performed for
every phenotype (P < 0.05). The permutation tests were car-
ried out to establish empirical significance thresholds for the
interactions. A threshold equal to or above the 37th percentile
(P = 0.63) was considered suggestively significant, and the
level for the significant threshold was set to the 95th percentile
(P = 0.05). Interval mapping was made with a 2 cM increase
under the additive regression model in order to calculate the
test statistics.Page 2 of 6
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The adult female mice were sacrificed at 15 months of age and
sera were collected. Anti-CII antibody titers in sera were ana-
lyzed by a sandwich ELISA technique [14]. In brief, CII (10 µg/
ml) was coupled to immunosorbent plates overnight at 4°C.
Bovine serum albumin (Sigma Chemical St Louis, MO, USA)
was used for blocking, and thereafter different dilutions of con-
trol sera (purified mouse anti-CII antibodies), test sera, and
positive and negative controls were added. The presence of
CII-specific IgG was visualized by means of peroxidase-conju-
gated goat antimouse IgG.
Statistical analysis
Statistical comparison between the different experimental
groups was performed using the Mann-Whitney U test or Stu-
dent's unpaired t test.
Results
NFR/N female mice show delayed onset and lower 
incidence of CIA compared with B10.Q females
The onset of the disease was significantly delayed in NFR/N
mice, which resulted in lower incidence in the initial phase of
the disease (Table 1 and Figure 1). The appearance of the
arthritis was slightly different between the two strains, NFR/N
mice showing a higher frequency of swelling of the entire paw
than B10.Q mice. Later in the disease course the differences
in CIA frequency and severity between the strains were less
obvious. However, the anti-CII titers 100 days after primary
immunization (and 70 days after the booster) differed signifi-
cantly between NFR/N and B10.Q female mice (see Table 1).
Pregnancy history does not significantly affect incidence 
or severity of CIA in female mice of mixed genetic 
background
Table 2 presents the results of arthritic incidence, arthritis
onset and maximum arthritic score for the female mice of the
N2 generation, (NFR/N × B10.Q) × B10.Q, grouped accord-
ing to the number of pregnancies they had experienced prior
to immunization with CII. There was no significant difference in
the incidence or severity of arthritis depending on the number
of pregnancies that had been passed prior to the induction of
the disease. We observed a trend towards lower severity in
multiparous mice compared with mice with a history of zero to
two pregnancies. The onset of diseases, however, was earlier
in mice that had passed more than one pregnancy.
There was no difference in the development of the disease
between female mice that have only been pregnant with MHC
mismatched males (B10.RIII) and female mice that only have
been pregnant with MHC matched males (B10.Q).
New loci associated with CIA in identified old female 
mice
The genetic linkage analysis revealed one significant quantita-
tive trait locus (QTL) located at 64–70 cM on chromosome 11
(Table 3 and Figure 2). This locus (denoted Cia40) gave sig-
nificant LOD scores for the traits incidence (LOD = 4.1) and
'day of onset' (LOD = 4.0), and a suggestive LOD score for
the trait 'arthritis score' (LOD = 3.3). Another QTL of sugges-
tive significance for the incidence of disease was identified
around 27 cM on chromosome 1 (Figure 2). Finally, a sugges-
tive QTL for the trait anti-CII antibody titer was identified on
chromosome 13 (Figure 2).
Figure 1
The accumulated incidence of arthritis in the parental strains (NFR/N and B10.Q) of female mice
and B10.Q) of female mice.
Table 1
Severity of arthritis and anti-collagen type II (anti-CII) titers in (NFR/N × B10.Q) × B10.Q female mice and parental strains
Generation n Day of onset (range)a Maximum scoreb Anti-CII titers (± standard 
error) (mg/ml) on day 100
F0 NFR/N 20 76.0 (11–102) 4.0 ± 1 1.53 ± 0.37c
F0 B10.Q 19 49.5 (12–69) 4.0 ± 1 0.87 ± 0.11
(NFR/N × B10.Q) × B10.Q 200 56.0 (8–105) 6.0 ± 0.2 1.63 ± 0.18
aMedian value on the days of onset when calculated in all arthritic mice in the group on day 100 (maximum–minimum values in the series).
bMean ± standard error of the maximum score from all arthritic mice in the respective group.
cSignificantly higher than in B10.Q mice (P = 0.02 in Student's unpaired t test).Page 3 of 6
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Although carrying the same CIA-susceptible MHC region, the
NFR/N and B10.Q mice are different in several respects. The
NFR/N mouse, which is an inbred NMRI mouse of the H-2q
haplotype, is larger in size than the B10.Q mouse and is also
known for its extraordinarily good breeding properties. The
mice used in the present study, (NFR/N × B10.Q) × B10.Q
females, first underwent a genetic study of reproduction, in
which a number of loci associated with breeding performance
were identified (Liljander M, Sällström MA, Andersson S,
Wernhoff P, Andersson Å, Holmdahl R, Mattsson R; unpub-
lished data). Since the parental strains differ in susceptibility to
CIA, in spite of both having the MHC class II A beta genes
[15], we wanted to test the susceptibility to inflammatory dis-
ease in mice from this cross. In fact, this situation gave an
opportunity to study the genetic control of arthritis in aged mul-
tiparous females, a common situation in human RA. This sus-
ceptibility was important to investigate for various reasons.
The fact that the mice differed in their reproductive history
made it possible to analyze whether this would significantly
affect the incidence or severity of CIA. Second, almost all the
linkage analyses performed for detection of CIA-associated
loci in mice have been carried out with male mice. Another rea-
son is that the use of old multiparous mice mimicked the RA
situation (older women is the major risk group). Finally, the
NFR/N strain had not previously been used in linkage analyses
for detection of CIA-associated loci, which opened (up) the
possibility of detecting new polymorphic genes of importance
in this disease.
The first conclusion from the present paper is that multiparity
does not negatively influence the incidence or severity of CIA
induced later in life (Table 2). This is in agreement with results
from a recent study of RA in women, which similarly indicates
that previous experience of pregnancy does not negatively
affect the incidence or severity of RA later in life [8]. It is worth
noting that the situation is quite different if pregnancy is
entered during ongoing arthritis. This will normally lead to a
temporary remission of the disease in both mice and humans,
followed by an exacerbation phase after delivery [7,10,11].
Table 3
Distribution of genotypes between affected and unaffected N2 mice at different loci linked to clinical phenotypes of collagen-
induced arthritis
Trait Locus Location (cM) Affected Unaffected LOD
Homozygote for B10.Q Heterozygote Homozygote for B10.Q Heterozygote
Incidence at day 100 D1Mit161 27.0 36 (71%) 15 (29%) 70 (48%) 75 (52%) 2.8*
D11Mit70 54.0 30 (58%) 21 (31%) 49 (34%) 96 (66%) 2.7*
D11Mit99 59.5 35 (69%) 16 (31%) 50 (35%) 95 (65%) 4.0**
D11Mit360 64.0 37 (73%) 14 (27%) 46 (31%) 99 (68%) 4.1**
D11Mit258 65.0 36 (71%) 15 (29%) 49 (34%) 96 (66%) 4.1**
D11Mit333 66.0 36 (71%) 15 (29%) 48 (33%) 97 (67%) 4.1**
D11Mit181 69.0 37 (73%) 14 (27%) 48 (33%) 97 (67%) 4.1**
D11Mit214 70.0 39 (76%) 12 (24%) 55 (38%) 90 (62%) 4.0*
*Suggestive significance, **significant.
Table 2
Incidence, onset and maximum score in (NFR/N × B10.Q) × B10.Q female mice
Number of pregnancies Number of mice Incidence on day 50 (%) Incidence on day 100 (%) Day of onset (range)a Maximum scoreb
0 10 10 40 62.0 (41–74) 5.5 ± 1
1 43 26 26 63.6 (31–145) 5.75 ± 0.9
2 84 13 20.5 55.3 (25–105) 6.3 ± 0.7
3 45 15 21.3 59.8 (31–76) 4.9 ± 0.8
4 18 11 27.8 51.0 (31–71) 4.2 ± 0.9
aMedian value on the days of onset when calculated in all arthritic mice in the group (maximum–minimum values in the series).
bMean (± standard error) of the maximum score from all arthritic mice in the respective group on day 100.Page 4 of 6
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importance for CIA have been detected, two associated with
arthritis susceptibility (chromosomes 1 and 11) and one asso-
ciated with anti-CII titers (chromosome 13). Some arthritis loci
have previously been identified on chromosome 1: Cia15 at 8
cM [16], Cia20 at 44 cM [16] and Cia9 at 92 cM [17]. How-
ever, none of these loci appears to be close to the locus found
on chromosome 1 in the present study. The newly identified
Cia40 locus includes the Ctla4 (CD152) gene, which is a
strong candidate associated with spontaneous diabetes iden-
tified in crosses between C57Bl and nonobese diabetic
strains [18]. Analyses of CIA in crosses of the same back-
grounds, however, did not identify a linkage to this locus, sug-
gesting that the polymorphism underlying Cia40 differs from
the genes associated with diabetes [18]. Interestingly, Bauer
and colleagues previously identified a locus (Cia28) associ-
ated with anti-CII antibody production at 53 cM on chromo-
some 13 [19], which is approximately at the same position as
where we find the linkage for this trait in the present study. It
is therefore most likely that the QTL we have identified on
chromosome 13 is the same as Cia28.
Since the possible new locus of potential interest on chromo-
some 1 was of suggestive significance, and since the locus
identified on chromosome 13 probably is Cia28, we are now
paying special attention to the significant QTL for CIA inci-
dence detected at 60–70 cM on chromosome 11 (denoted
Cia40). No other CIA genes have previously been typed in this
region, but the central part of chromosome 11 is known to
contain a number of inflammation loci, such as Eae22, Eae6b,
Eae23 and Eae7 [20-22]. One QTL for proteoglycan-induced
arthritis, which was female specific for disease onset, have
also been found on chromosome 11. Although this locus
(Pgia28) is not located in the vicinity of Cia40, it is worth not-
ing [23].
The mouse chromosome 11 contains several genes that are
highly conserved with human chromosome 17. Linkages for
human RA have been found in this particular region [24].
Another interesting locus is Cia5 on the homolog rat chromo-
some 10, which regulates the severity of CIA and pristane-
induced arthritis [25].
Interestingly, from studies with the same cross, we have previ-
ously detected a significant QTL denoted Pregq2 for the trait
'pregnancy frequency' in the very same region as Cia40 (peak
at 64–70 cM on chromosome 11) (Liljander M, Sällström MA,
Andersson S, Wernhoff P, Andersson Å, Holmdahl R, Matts-
son R, unpublished data). This means that this region contains
genes affecting the CIA incidence in multiparous mice in addi-
tion to the rate of successful deliveries in female mice. The
'pregnancy rate' in mice is defined as successful pregnancies
per detected vaginal plug, a phenotype associated with early
pregnancy failure, which in turn possibly could have an inflam-
matory cause. We cannot exclude that the same gene(s) are
affecting both these traits.
Figure 2
Chromosomal locations of the quantitative trait loci (QTL) for collagen-induced arthritis incidence on chromosomes 1 and 11i l i  f r ll -i  rt riti  i i   chro oso es  and 11. QTL for collagen type 
II (CII) antibody titers are illustrated on chromosome 13. *Suggestive level threshold (P = 0.63) according to the permutation test (n = 1,000). ** Sig-
nificance level threshold (P = 0.05) according to the permutation test (n = 1,000).Page 5 of 6
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Our results show that multiparity does not negatively influence
the incidence or severity of CIA induced later in life. Further-
more, two new loci linked to CIA susceptibility were detected
on chromosome 11 (Cia40) and on chromosome 1. We
detected on chromosome 13 a locus associated with anti-CII
titers, which probably is the same as the recently reported
Cia28 [19].
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